Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Benitec Biopharma Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 22 | 1 | 25 | +4 |
| Shares | 1.34M | 3 | 15.9M | +14.6M (+1,088.4%) |
| Value | $1.55M | $0 | $5.92M | +$4.36M (+281.4%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Benitec Biopharma Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Franklin Resources Inc | 10,000,000 | $3.72M | 0.00% |
| Armistice Capital, LLC | 1,555,039 | $578.0K | 0.01% |
| CVI Holdings, LLC | 1,289,128 | $479.0K | 0.04% |
| Empery Asset Management, LP | 796,837 | $296.0K | 1.76% |
| Altium Capital Management LP | 658,796 | $245.0K | 0.09% |
| Walleye Capital LLC | 190,678 | $71.0K | 0.00% |
| Cantor Fitzgerald, L. P. | 133,805 | $50.0K | 0.00% |
| Renaissance Technologies LLC | 120,429 | $45.0K | 0.00% |
| Two Sigma Investments, LP | 38,838 | $14.0K | 0.00% |
| Cutler Group LP | 1,000 | $0 | 0.00% |
Sold out (6)
Institutions that held Benitec Biopharma Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Barclays PLC | 136,307 | $158.0K |
| Susquehanna International Group, LLP | 53,886 | $62.0K |
| Citadel Advisors LLC | 49,964 | $58.0K |
| Virtu Financial LLC | 47,393 | $55.0K |
| Two Sigma Securities, LLC | 24,270 | $28.0K |
| Citigroup Inc | 3,440 | $4.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Benitec Biopharma Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Fieldpoint Private Securities, LLC | 3 | $0 |